New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
10:00 EDTCICigna names Mary Picerno Chief Nursing Officer
Prior to joining Cigna, Picerno was staff vice president for WellPoint.
News For CI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 10, 2016
07:15 EDTCILeerink to hold a conference
Subscribe for More Information
February 9, 2016
12:15 EDTCIAddus HomeCare served with 'whistleblower' suit over referrals
Subscribe for More Information
February 8, 2016
09:38 EDTCICigna enters into outcomes-based contract with Novartis
Cigna (CI) has entered into an outcomes-based contract with the pharmaceutical company Novartis (NVS) for the drug Entresto, which was approved by the FDA for the treatment of heart failure with reduced ejection fraction. The pay-for-performance agreement ties the financial terms to how well the drug improves the relative health of Cigna's customers. The primary metric is reduction in the proportion of customers with heart failure hospitalizations. This agreement is effective for Cigna's commercial business. Entresto is a preferred brand subject to prior authorization review. The prior authorization process is part of utilization management to help control prescription drug costs and ensure coverage of the most appropriate drug therapies.
February 7, 2016
14:45 EDTCILeerink healthcare services analyst holds analyst/industry conference call
Subscribe for More Information
February 4, 2016
06:16 EDTCICigna reports Q4-end Commercial customers 14.43M, Government customers 567K
Reports Q4 Total Commercial medical care ratio of 80.4%, Total Government medical care ratio of 83.1%. Full year medical cost trend for our total U.S. Commercial book of business was approximately 5% and reflects continued favorable medical costs, physician engagement and low utilization trend.
06:15 EDTCICigna unlikely to make further share repurchases in 2016
Cites the pending combination with Anthem.
06:03 EDTCICigna sees FY16 adjusted EPS $8.85-$9.25, consensus $9.30
Subscribe for More Information
06:02 EDTCICigna reports Q4-end global medical customers 14.99M
Subscribe for More Information
06:01 EDTCICigna reports Q4 adjusted EPS $1.87, consensus $1.80
Reports Q4 revenue $9.53B, consensus $9.52B.
February 3, 2016
14:48 EDTCINotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Philip Morris (PM), consensus 81c... AstraZeneca (AZN), consensus 88c... Occidental Petroleum (OXY), consensus (12c)... ConocoPhillips (COP), consensus (65c)... Cigna (CI), consensus $1.80... Intercontinental Exchange (ICE), consensus $3.01... Boston Scientific (BSX), consensus 25c... Charter Communications (CHTR), consensus (12c)... Ralph Lauren (RL), consensus $2.13... Dunkin' Brands (DNKN), consensus 50c... GrubHub (GRUB), consensus 14c... Level 3 (LVLT), consensus 53c... AmerisourceBergen (ABC), consensus $1.25... Cummins (CMI), consensus $2.11.
06:55 EDTCICigna volatility elevated into Q4 and outlook
Cigna February call option implied volatility is at 28, March is at 29 ; compared to its 52-week range of 18 to 39, suggesting large near term price movement into the expected release of Q4 results on February 4.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use